Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L. Sullivan

Showing results (281-290 of 301) with videos related to

Pageof 31
Sort By:
Antimicrobial Agents and Chemotherapy|February 1, 1993
Pharmacokinetics of nevirapine: initial single-rising-dose study in humansS H Cheeseman, S E Hattox, M M McLaughlin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 12, 2001
Infrequent detection of HIV-1-specific, but not cytomegalovirus-specific, CD8(+) T cell responses in young HIV-1-infected infantsZ A Scott, E G Chadwick, L L Gibson, et al.
Clinical Pharmacology and Therapeutics|July 14, 2001
Population pharmacokinetics of dapsone in children with human immunodeficiency virus infectionM Mirochnick, E Cooper, E Capparelli, et al.
The Journal of Infectious Diseases|April 1, 1986
Serological characterization of HTLV-III infection in AIDS and related disordersJ E Groopman, F W Chen, J A Hope, et al.
Human Genetics|July 1, 1989
Linkage analysis of seven kindreds with the X-linked lymphoproliferative syndrome (XLP) confirms that the XLP locus is near DXS42 and DXS37J C Skare, H L Grierson, J L Sullivan, et al.
The Journal of Pain|April 5, 2023
Establishing the Reliability, Validity, and Prognostic Utility of the Momentary Pain Catastrophizing Scale for Use in Ecological Momentary Assessment ResearchMadelyn R Frumkin, Jacob K Greenberg, Preston Boyd, et al.
The Journal of Pediatrics|April 1, 1986
Hemophiliac immunodeficiency: influence of exposure to factor VIII concentrate, LAV/HTLV-III, and herpesvirusesJ L Sullivan, F E Brewster, D B Brettler, et al.
The New England Journal of Medicine|June 12, 1997
Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 TeamJ A Englund, C J Baker, C Raskino, et al.
Psychological Bulletin|June 7, 2011
A biopsychosocial formulation of pain communicationThomas Hadjistavropoulos, Kenneth D Craig, Steve Duck, et al.
The Pediatric Infectious Disease Journal|June 3, 1999
Toxicity and efficacy of daily vs. weekly dapsone for prevention of Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus. ACTG 179 Study Team. AIDS Clinical Trials GroupK McIntosh, E Cooper, J Xu, et al.
Pageof 31

Showing results (281-290 of 301) with videos related to

Sort By:
Pageof 31
Antimicrobial Agents and Chemotherapy|February 1, 1993
Pharmacokinetics of nevirapine: initial single-rising-dose study in humansS H Cheeseman, S E Hattox, M M McLaughlin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 12, 2001
Infrequent detection of HIV-1-specific, but not cytomegalovirus-specific, CD8(+) T cell responses in young HIV-1-infected infantsZ A Scott, E G Chadwick, L L Gibson, et al.
Clinical Pharmacology and Therapeutics|July 14, 2001
Population pharmacokinetics of dapsone in children with human immunodeficiency virus infectionM Mirochnick, E Cooper, E Capparelli, et al.
The Journal of Infectious Diseases|April 1, 1986
Serological characterization of HTLV-III infection in AIDS and related disordersJ E Groopman, F W Chen, J A Hope, et al.
Human Genetics|July 1, 1989
Linkage analysis of seven kindreds with the X-linked lymphoproliferative syndrome (XLP) confirms that the XLP locus is near DXS42 and DXS37J C Skare, H L Grierson, J L Sullivan, et al.
The Journal of Pain|April 5, 2023
Establishing the Reliability, Validity, and Prognostic Utility of the Momentary Pain Catastrophizing Scale for Use in Ecological Momentary Assessment ResearchMadelyn R Frumkin, Jacob K Greenberg, Preston Boyd, et al.
The Journal of Pediatrics|April 1, 1986
Hemophiliac immunodeficiency: influence of exposure to factor VIII concentrate, LAV/HTLV-III, and herpesvirusesJ L Sullivan, F E Brewster, D B Brettler, et al.
The New England Journal of Medicine|June 12, 1997
Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 TeamJ A Englund, C J Baker, C Raskino, et al.
Psychological Bulletin|June 7, 2011
A biopsychosocial formulation of pain communicationThomas Hadjistavropoulos, Kenneth D Craig, Steve Duck, et al.
The Pediatric Infectious Disease Journal|June 3, 1999
Toxicity and efficacy of daily vs. weekly dapsone for prevention of Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus. ACTG 179 Study Team. AIDS Clinical Trials GroupK McIntosh, E Cooper, J Xu, et al.
Pageof 31